Revenue segments as reported by the company.

Electronics & Industrial

Water & Protection

Corporate & Other

Mobility & Materials

Corporate

Electronics & Imaging

Nutrition & Biosciences

Transportation & Industrial

Safety & Construction

Non-Core

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development expenses

Selling, general and administrative expenses

Amortization of intangibles

Restructuring and asset related charges - net

Goodwill impairment charges

Acquisition, integration and separation costs

Equity in earnings of nonconsolidated affiliates

Sundry income (expense) - net

Interest expense

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

DuPont de Nemours

Danisco is a Danish bio-based company with activities in food production, enzymes and other bioproducts as well as a wide variety of pharmaceutical grade excipients. It was formed in 1989 from the largest Danish industrial merger ever of the two old C.F. Tietgen companies Danish Sugar (founded 1872), and Dansk Handels- og Industri Company (Danisco A/S).

Danisco

Solae was an international soy ingredients supplier based in St. Louis, Missouri. Solae was formed as a joint venture between DuPont and Bunge Limited. On May 1, 2012, Solae announced that DuPont had acquired Bunge's 28% share, thus taking full ownership of the company. DuPont then merged Solae's business into Danisco. The company developed food, feed and industrial ingredients, focusing on soy. Many of the studies supporting the Food and Drug Administration-approved health claim were based on research using Solae soy protein.

Solae

DuPont de Nemours, Inc. is a holding company, which engages in the development of specialty materials, chemicals, and agricultural products. It operates through the following segments: Electronics and Industrial, Water and Protection, and Corporate and Others. The Electronics and Industrial segment involves the supply of differentiated materials and systems for a broad range of consumer electronics including mobile devices, television monitors, personal computers and electronics used in a variety of industries. The Water and Protection segment focuses on the provision of engineered products and integrated systems for many industries including worker safety, water purification and separation, aerospace, energy, medical packaging and building materials. The company was founded in 1897 and is headquartered in Wilmington, DE.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

DuPont reports strong Q4 results, eyes growth amid challenges

DuPont's Q4 performance showcased organic revenue growth and margin improvement, supported by strategic actions and portfolio transformation.
While facing challenges in the shelter business and market conditions, DuPont remains focused on innovation, growth opportunities, and shareholder value enhancement.
The company's outlook for 2023 includes solid top-line growth, operational targets, and a strategic focus on managing challenges and leveraging growth opportunities.

DuPont exceeds Q1 expectations, eyes healthcare growth amid market challenges

DuPont's Q1 performance was solid, with revenue and adjusted EPS surpassing guidance, driven by acquisitions and ongoing market strengths. Challenges in the electronics market and inventory destocking impacted full-year guidance, but opportunities for growth in healthcare and other sectors are on the horizon. The company's focus on sustainability and operational efficiency remains key.

DuPont reports resilient Q2 performance amidst market challenges

DuPont's Q2 performance showed resilience amid market challenges, with a focus on strategic priorities for long-term growth.
While facing volume pressures and market uncertainties, DuPont is leveraging acquisitions and cost controls to drive value.
Opportunities lie in sequential business improvements, cost reductions, and sustainability-focused sales strategies.
Challenges include market-specific declines and regional growth variations that require strategic adjustments.

DuPont reports solid Q3 earnings amidst China challenges and growth opportunities

DuPont's Q3 performance showcased resilience amid challenges, with revenue declines offset by improved margins and EPS growth. Strategic acquisitions and divestitures are driving the company forward.
Despite facing headwinds in China and inventory destocking, DuPont is capitalizing on opportunities in semiconductors and other key segments. Efforts to enhance efficiency and target growth areas position the company for future success.
While challenges like trade restrictions and industrial destocking persist, DuPont remains focused on leveraging growth opportunities in AI, electronics, and other segments. Maintaining a strong cash position and returning value to shareholders are key priorities.

DuPont reports Q4 2023 results, eyes growth in key markets

DuPont's Q4 performance saw declines in net sales and EBITDA, but the company remains resilient amidst market challenges. Cost-saving initiatives and share repurchase programs demonstrate strategic financial management.
Despite absorption headwinds and challenges in China, DuPont's focus on key markets like semiconductors and water positions it for growth. The company's long-term EBITDA margin outlook is positive.
Opportunities in market stabilization, recovery in key sectors, and potential growth in water and electronics segments offer DuPont avenues for future expansion and profitability.

DuPont surpasses Q1 expectations, eyes growth amid market challenges

DuPont's Q1 2024 performance exceeded expectations, prompting an upward revision of full-year guidance across key financial metrics.
The company's focus on operational excellence, sustainability, and market diversification positions it well for recovery and growth in 2024 and beyond.
While facing challenges in pricing and market dynamics, DuPont's strategic initiatives and opportunities in key segments offer avenues for future growth.
Overall, DuPont's strong performance, prudent risk management, and focus on innovation and efficiency underscore its resilience and potential for sustained success.

DuPont surpasses Q2 expectations, eyes growth in tech and China

DuPont delivered strong Q2 2024 results, exceeding guidance and showcasing resilience across key segments.
Strategic initiatives like the Donatelle acquisition and planned separation activities position DuPont for future growth and market leadership.
While legal challenges persist, DuPont's proactive approach and focus on innovation and diversification bode well for long-term success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Archer-Daniels-Midland Company

American Electric Power Company

Aflac

Bank of America

Corteva Inc

Chevron

Dominion Energy

Discover

Dow Inc

Con Ed

Emerson Electric

FirstEnergy

iShares Core S&P Total U.S. Stock Market ETF

Johnson & Johnson

Kraft Heinz

Kroger

McDonald's

Norfolk Southern

Pfizer

J. M. Smucker

Scotts Miracle-Gro

In December, we received $4,699.20 in dividend income. That is a 23.4% increase compared to last year. We received $3,500 from our retirement accounts this month alone. In total, our dividend income increased nearly $10 from dividend increases.

Dividend Income Summary: Bert's December 2020 Summary - New Record

Why you should depend on the DuPont technique to pick solid profit-generating stocks.

4 Top-Ranked Stocks to Make the Most of DuPont Analysis

International Flavors & Fragrances

International Flavors (IFF) projects run rate revenue synergies of $400 million by the end of 2023.

International Flavors (IFF) Issues Guidance on DuPont Integration

WILMINGTON, Del., Dec. 31, 2020 /PRNewswire/ -- DuPont (NYSE: DD) today announced the commencement of its exchange offer (split-off) whereby DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. ("N&B") common stock....

DuPont Launches Split-Off Exchange Offer for its Nutrition and Biosciences Business and Announces Record Date for Expected Clean-Up Spin-Off in Connection with IFF Transaction

Intel

Thermo Fisher Scientific

Arrowhead Pharmaceuticals

Onto Innovation

Veeco Instruments

Seven nanotech stocks to buy have the potential to reward investors as innovation in the sector accelerates. The post 7 Nanotech Stocks To Buy With Huge Returns in Store appeared first on InvestorPlace.

7 Nanotech Stocks To Buy With Huge Returns in Store

Investors need to pay close attention to DuPont (DD) stock based on the movements in the options market lately.

Implied Volatility Surging for DuPont (DD) Stock Options

DuPont de Nemours Inc. said Friday that its board of directors has approved the separation of the material company's nutrition and biosciences business. Under terms of the "split-off," DuPont shareholders can choose to tender DuPont common shares for Nutrition & Biosciences (N&B) common stock.

DuPont board OKs separation of Nutrition & Biosciences business before International Flavors merger

WILMINGTON, Del., Dec. 18, 2020 /PRNewswire/ -- DuPont (NYSE: DD) today announced that its Board of Directors has approved the separation of DuPont's Nutrition & Biosciences business through an exchange offer (split-off) whereby DuPont stockholders can elect to tender shares of DuPont...

DuPont Board of Directors Approves the Separation of DuPont's Nutrition & Biosciences Business through an Exchange Offer

NEW YORK & WILMINGTON, Del.--(BUSINESS WIRE)---- $IFF--Regulatory News: IFF (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF) and DuPont (NYSE: DD) today announced that the intended combination of DuPont's Nutrition & Biosciences (N&B) business with IFF has received unconditional clearance from the European Commission. With receipt of this clearance, the intended combination has received all required antitrust clearances and approvals that are a condition to the closing of the transaction. “We are p

IFF Receives All Required Antitrust Clearances for Intended Combination with DuPont's Nutrition & Biosciences Business

Eastman Chemical

Buyers bid up chemical stocks Friday on hopes of improving manufacturing activity. Trade two leading names with these tactical ideas.

Chemical Stocks React Positively to Growing Factory Orders

Univar

Univar's (UNVR) ChemPoint selected as distributor of DuPont's cellulosic and poly offerings in industrial applications.

Univar (UNVR) Unit Selected as Distributor by DuPont in Mexico

Have more faith in DuPont analysis than in simple ROE calculation? Bet on these five stocks.

5 Top-Ranked Stocks to Make the Most of DuPont Analysis

Rhizome Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 2.9% for the third quarter (net of fees), underperforming its benchmark, the S&P 500 Index which returned 8.9% in the same quarter. You should check out Rhizome Partners' top 5 stock picks for investors to buy right now, which could be the biggest winners of this year.

Is DuPont de Nemours (DD) a Smart Long-term Buy?

DuPont de Nemours' (DD) CEO Ed Breen on Q3 2020 Results - Earnings Call Transcript

DuPont (DD) saw strong demand in semiconductors, smartphones, water, Tyvek protective garments and health & wellness in Q3. It raised its cost-savings target for 2020.

DuPont (DD) Beats on Q3 Earnings, Lifts Cost-Cutting Target

Shares of DuPont de Nemours (NYSE:DD) rose 0.5% in pre-market trading after the company reported Q3 results.

DuPont: Q3 Earnings Insights

DuPont's (DD) adjusted earnings of 88 cents per share for the third quarter surpassed the Zacks Consensus Estimate of 77 cents.

DuPont's (DD) Q3 Earnings and Revenues Beat Estimates

Industrial materials maker DuPont on Thursday forecast full-year profit above Wall Street expectations as it kept a tight check on costs and benefited from a recovery in the automotive industry, one of it biggest markets.

DuPont sees strong annual profit as auto sector recovers, signals more cost cuts

WILMINGTON, Del., Oct. 29, 2020 /PRNewswire/ -- DuPont (NYSE: DD) today announced financial results for the third quarter 2020. "Our team remains committed to emphasizing the safety and well-being of our employees, prioritizing the needs of our customers, and executing on a playbook that...

DuPont Reports Third Quarter 2020 Results

DuPont de Nemours Inc. swung to a third-quarter net loss, but reported an adjusted profit that beat and revenue that fell less than expectation and provided an upbeat full-year outlook. The technology-based materials company's stock was still inactive in premarket trading.

DuPont beats adjusted profit, revenue expectations and provides upbeat outlook

Benefits of cost synergy savings and productivity actions are expected to get reflected on DuPont's (DD) third-quarter results.

DuPont (DD) Gears Up for Q3 Earnings: What's in the Cards?

Air Products and Chemicals

Ecolab

Fidelity MSCI Materials Index ETF

iShares U.S. Basic Materials ETF

New Linde PLC

Newmont Mining

Vanguard Materials ETF

Materials Select Sector SPDR Fund

With positive earnings estimate revision and earnings surprises in the cards, materials ETFs might continue to see smooth trading in the weeks ahead.

ETFs to Watch on Likely Q3 Earnings Surprise for Materials

Axalta Coating Systems

Rayonier Advanced Materials

Improved end-market demand and benefits of self-help actions are likely to reflect on the Q3 performance of Axalta Coating (AXTA), Rayonier (RYAM), Dow (DOW), DuPont (DD) and Eastman (EMN).

5 Chemical Stocks Likely to Outshine Q3 Earnings Estimates

News for DuPont de Nemours Stock (DD)